Insider · CIK 0001846325
Lisa DeFrancesco
Files at LXRX (LEXICON PHARMACEUTICALS, INC.). First filing -, latest -.
Lisa DeFrancesco files SEC Form 4 as officer at LXRX (LEXICON PHARMACEUTICALS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Lisa DeFrancesco has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Common Stock | +24,674 | - | - | 40,251 | Mar 3, 2026 |
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Common Stock | +128,190 | - | - | 168,441 | Mar 3, 2026 |
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | FTax withholding Common Stock | -74,572 | $1.47 | $110k | 93,869 | Mar 3, 2026 |
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -24,674 | - | - | 24,673 | Mar 3, 2026 |
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -128,190 | - | - | 256,380 | Mar 3, 2026 |
| Feb 12, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitsderivative | +257,530 | $0.00 | $0 | 257,530 | Feb 17, 2026 |
| Feb 12, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +386,300 | $0.00 | $0 | 386,300 | Feb 17, 2026 |
| Feb 28, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Common Stock | +24,673 | - | - | 24,673 | Mar 3, 2025 |
| Feb 28, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | FTax withholding Common Stock | -9,096 | $0.67 | $6,094 | 15,577 | Mar 3, 2025 |
| Feb 28, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -24,673 | - | - | 49,347 | Mar 3, 2025 |
| Feb 13, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +576,850 | $0.00 | $0 | 576,850 | Feb 18, 2025 |
| Feb 13, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitsderivative | +384,570 | $0.00 | $0 | 384,570 | Feb 18, 2025 |
Questions about Lisa DeFrancesco
Answered from the filings on this page, as of the latest one.
Is Lisa DeFrancesco buying or selling?
Lisa DeFrancesco has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Lisa DeFrancesco's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lisa DeFrancesco has 0.
Where does Lisa DeFrancesco file Form 4?
Lisa DeFrancesco has filed Form 4 at LXRX (LEXICON PHARMACEUTICALS, INC.) as SVP, IR and Corp Comm. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.